These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25026294)

  • 1. Acquisition of radioresistance in docetaxel-resistant human lung adenocarcinoma cells is linked with dysregulation of miR-451/c-Myc-survivin/rad-51 signaling.
    Wang R; Chen DQ; Huang JY; Zhang K; Feng B; Pan BZ; Chen J; De W; Chen LB
    Oncotarget; 2014 Aug; 5(15):6113-29. PubMed ID: 25026294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-451 induces epithelial-mesenchymal transition in docetaxel-resistant lung adenocarcinoma cells by targeting proto-oncogene c-Myc.
    Chen D; Huang J; Zhang K; Pan B; Chen J; De W; Wang R; Chen L
    Eur J Cancer; 2014 Nov; 50(17):3050-67. PubMed ID: 25310895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Let-7c governs the acquisition of chemo- or radioresistance and epithelial-to-mesenchymal transition phenotypes in docetaxel-resistant lung adenocarcinoma.
    Cui SY; Huang JY; Chen YT; Song HZ; Feng B; Huang GC; Wang R; Chen LB; De W
    Mol Cancer Res; 2013 Jul; 11(7):699-713. PubMed ID: 23562878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2.
    Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X
    Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDAC 1/4-mediated silencing of microRNA-200b promotes chemoresistance in human lung adenocarcinoma cells.
    Chen DQ; Pan BZ; Huang JY; Zhang K; Cui SY; De W; Wang R; Chen LB
    Oncotarget; 2014 May; 5(10):3333-49. PubMed ID: 24830600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway.
    Pan Y; Chen J; Tao L; Zhang K; Wang R; Chu X; Chen L
    Oncotarget; 2017 May; 8(20):33144-33158. PubMed ID: 28388536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-200b regulates autophagy associated with chemoresistance in human lung adenocarcinoma.
    Pan B; Feng B; Chen Y; Huang G; Wang R; Chen L; Song H
    Oncotarget; 2015 Oct; 6(32):32805-20. PubMed ID: 26416454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MARCKSL1-2 reverses docetaxel-resistance of lung adenocarcinoma cells by recruiting SUZ12 to suppress HDAC1 and elevate miR-200b.
    Jiang M; Qi F; Zhang K; Zhang X; Ma J; Xia S; Chen L; Yu Z; Chen J; Chen D
    Mol Cancer; 2022 Jul; 21(1):150. PubMed ID: 35864549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-650 was a prognostic factor in human lung adenocarcinoma and confers the docetaxel chemoresistance of lung adenocarcinoma cells via regulating Bcl-2/Bax expression.
    Huang JY; Cui SY; Chen YT; Song HZ; Huang GC; Feng B; Sun M; De W; Wang R; Chen LB
    PLoS One; 2013; 8(8):e72615. PubMed ID: 23991130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3.
    Feng B; Wang R; Song HZ; Chen LB
    Cancer; 2012 Jul; 118(13):3365-76. PubMed ID: 22139708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase 1/Sp1/microRNA-200b signaling accounts for maintenance of cancer stem-like cells in human lung adenocarcinoma.
    Chen DQ; Huang JY; Feng B; Pan BZ; De W; Wang R; Chen LB
    PLoS One; 2014; 9(10):e109578. PubMed ID: 25279705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1.
    Feng B; Wang R; Chen LB
    Cancer Lett; 2012 Apr; 317(2):184-91. PubMed ID: 22120675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of ING4 (inhibitor of growth 4) as a modulator of docetaxel sensitivity in human lung adenocarcinoma.
    Wang R; Huang J; Feng B; De W; Chen L
    Mol Med; 2012 Jul; 18(1):874-86. PubMed ID: 22460125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-409-3p functions as a tumor suppressor in human lung adenocarcinoma by targeting c-Met.
    Wan L; Zhu L; Xu J; Lu B; Yang Y; Liu F; Wang Z
    Cell Physiol Biochem; 2014; 34(4):1273-90. PubMed ID: 25278243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA CCAT1 acts as an oncogene and promotes chemoresistance in docetaxel-resistant lung adenocarcinoma cells.
    Chen J; Zhang K; Song H; Wang R; Chu X; Chen L
    Oncotarget; 2016 Sep; 7(38):62474-62489. PubMed ID: 27566568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic downregulation of RUNX3 by DNA methylation induces docetaxel chemoresistance in human lung adenocarcinoma cells by activation of the AKT pathway.
    Zheng Y; Wang R; Song HZ; Pan BZ; Zhang YW; Chen LB
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2369-78. PubMed ID: 23892093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-negative feedback loop between E2F3b and miR- 200b regulates docetaxel chemosensitivity of human lung adenocarcinoma cells.
    Gao Y; Chen L; Song H; Chen Y; Wang R; Feng B
    Oncotarget; 2016 May; 7(19):27613-26. PubMed ID: 27027446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-141 regulation of EIF4E expression affects docetaxel chemoresistance of non-small cell lung cancer.
    Wang D; Ma J; Ji X; Xu F; Wei Y
    Oncol Rep; 2017 Jan; 37(1):608-616. PubMed ID: 27840955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma.
    Pan B; Chen D; Huang J; Wang R; Feng B; Song H; Chen L
    Mol Cancer; 2014 Jul; 13():165. PubMed ID: 24996221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsa_circ_0003998 Promotes Chemoresistance via Modulation of miR-326 in Lung Adenocarcinoma Cells.
    Yu W; Peng W; Sha H; Li J
    Oncol Res; 2019 May; 27(5):623-628. PubMed ID: 30764896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.